TopGum Appoints Ofra Strauss to Board of Directors
News related to:TopGum Industries Ltd · 2 min read
SDEROT and RAMAT GAN, Israel, Nov. 12, 2026 /CourierPR/ -- TopGum Industries Ltd., a global dietary supplements company based in Sderot, Israel, has appointed Ofra Strauss, Chairperson of Strauss Group since 2001, to its Board of Directors. This move comes at a pivotal stage for the company, as it continues to expand its presence in international markets and innovate in the health and nutrition sector.
Founded in 2004, TopGum has grown to become a leading manufacturer of gummy dietary supplements, operating production sites in Israel, Canada, and the United States. The company currently employs more than 400 people and has been experiencing significant growth. In the second quarter of 2026, TopGum reported its tenth consecutive record quarter, with revenue of approximately $33.8 million and organic growth of approximately 50%. First-half Group revenue totaled approximately $65.7 million, up approximately 65%, and the order backlog in the dietary supplements segment reached a record of approximately $57 million. The company expects revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million.
Ms. Strauss's appointment is part of a series of senior appointments TopGum has made in recent years, including Raviv Zoller, former CEO of ICL Group, as Executive Chairman, and Eyal Shohat, former CEO of SodaStream, as Chief Executive Officer. The connection between Ofra Strauss and TopGum reflects a shared commitment to Israeli industry in Sderot and to connecting local roots with global growth. Sderot and the Negev have long been part of Ms. Strauss's work, much like TopGum, which grew from Sderot to the world.
TopGum's recent acquisitions have further solidified its position in the global market. In May 2026, the company completed the acquisition of PL Developments' U.S. gummy manufacturing operations, giving TopGum its first physical presence in its primary target market and a foothold in the pharmaceutical space. The transaction followed the 2025 acquisition of the operations of Canada-based Island Abbey.
As TopGum continues to grow and expand, the appointment of Ofra Strauss to its Board of Directors is expected to bring significant expertise and strategic insights to the company's leadership team. With its strong financial performance and a robust pipeline of products, TopGum is well-positioned to continue its journey of innovation and global expansion.